Testosterone therapy: increased risk of CV events

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1489卷 / 1期

关键词：

D O I：

10.1007/s40278-014-8882-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] Testosterone therapy associated with increased risk of cardiovascular events
Nature Reviews Cardiology, 2014, 11 (1) : 2 - 2
[2] Testosterone products: increased risk of CV disorders
Reactions Weekly, 2016, 1588 (1) : 4 - 4
[3] Celecoxib: no increased risk of CV events
Reactions Weekly, 2002, 892 (1) : 4 - 4
[4] Testosterone replacement therapy increase risks of CV events
Reactions Weekly, 2019, 1764 (1) : 13 - 13
[5] Testosterone therapy in men not linked to increased CV risks?
Reactions Weekly, 2015, 1542 (1) : 13 - 13
[6] New evidence of CV risk with testosterone therapy
Reactions Weekly, 2014, 1484 (1) : 3 - 3
[7] No increased risk of CV events with dutasteride vs finasteride
Reactions Weekly, 2016, 1630 (1) : 9 - 9
[8] INCREASED RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN MEN RECEIVING TESTOSTERONE REPLACEMENT THERAPY
Mann, Uday
Brar, Ranveer
Patel, Premal
JOURNAL OF UROLOGY, 2022, 207 (05): : E833 - E833
[9] INCREASED RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN TESTOSTERONE DEFICIENT MEN AND IN MEN RECEIVING TESTOSTERONE REPLACEMENT THERAPY
Mann, U.
Bal, D.
Brar, R.
Patel, P.
JOURNAL OF SEXUAL MEDICINE, 2023, 20
[10] Risk of urolithiasis increased with testosterone replacement therapy
Stone L.
Nature Reviews Urology, 2019, 16 (6) : 330 - 330

← 1 2 3 4 5 →